Literature DB >> 20363983

Effects of voluntarily-ingested buprenorphine on plasma corticosterone levels, body weight, water intake, and behaviour in permanently catheterised rats.

Renée Goldkuhl1, Jann Hau, Klas S P Abelson.   

Abstract

This study investigated the peri- and postoperative effect of pre-emptive analgesia through voluntary ingestion of buprenorphine in Nutella, in male Sprague-Dawley rats. An arterial catheter was inserted and the rats were connected to an automated blood sampling device (AccuSampler). Blood samples were drawn up to 18 h after surgery and the plasma concentrations of corticosterone were quantified. Postoperative changes in water intake and body weight were recorded, and the behaviour of the rats was analysed during two 30-min periods. Pre-emptive oral buprenorphine treatment reduced the plasma corticosterone levels in the postoperative period, compared to controls treated with local anaesthetics. Buprenorphine-treated rats consumed more water and maintained body weight better. Behavioural observations indicated that buprenorphine changed the behaviour in non-operated rats but there was no difference in the operated rats. The present study strengthens the hypothesis that pre-emptive oral buprenorphine in Nutella is suitable for treatment of postoperative pain in rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363983

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  13 in total

1.  Evaluation of a Commercially Available Euthanasia Solution as a Voluntarily Ingested Euthanasia Agent in Laboratory Mice.

Authors:  Emily S Dudley; Gregory P Boivin
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-01-01       Impact factor: 1.232

2.  Voluntary Oral Administration of Losartan in Rats.

Authors:  Lucília N Diogo; Inês V Faustino; Ricardo A Afonso; Sofia A Pereira; Emília C Monteiro; Ana I Santos
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-09       Impact factor: 1.232

3.  Analgesic Efficacy of Subcutaneous-Oral Dosage of Tramadol after Surgery in C57BL/6J Mice.

Authors:  Rocio Evangelista-Vaz; Alessandra Bergadano; Margarete Arras; Paulin D Jirkof
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-06-05       Impact factor: 1.232

4.  A glucocorticoid receptor antagonist reduces sign-tracking behavior in male Japanese quail.

Authors:  Beth Ann Rice; Shannon E Eaton; Mark A Prendergast; Chana K Akins
Journal:  Exp Clin Psychopharmacol       Date:  2018-06-07       Impact factor: 3.157

5.  Analgesic Activity of Tramadol and Buprenorphine after Voluntary Ingestion by Rats (Rattus norvegicus).

Authors:  Bryan F Taylor; Harvey E Ramirez; August H Battles; Karl A Andrutis; John K Neubert
Journal:  J Am Assoc Lab Anim Sci       Date:  2016-01       Impact factor: 1.232

6.  Clinical Management of Pain in Rodents.

Authors:  Patricia L Foley; Lon V Kendall; Patricia V Turner
Journal:  Comp Med       Date:  2019-12-10       Impact factor: 0.982

7.  Transdermal Fentanyl Solution Provides Long-term Analgesia in the Hind-paw Incisional Model of Postoperative Pain in Male Rats.

Authors:  Johanne Clemensen; Lena V Rasmussen; Klas S P Abelson
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

8.  Manual versus automated blood sampling: impact of repeated blood sampling on stress parameters and behavior in male NMRI mice.

Authors:  A C Teilmann; Otto Kalliokoski; Dorte B Sørensen; Jann Hau; Klas S P Abelson
Journal:  Lab Anim       Date:  2014-06-23       Impact factor: 2.471

9.  Physiological and pathological impact of blood sampling by retro-bulbar sinus puncture and facial vein phlebotomy in laboratory mice.

Authors:  Anne Charlotte Teilmann; Andreas Nygaard Madsen; Birgitte Holst; Jann Hau; Björn Rozell; Klas Stig Peter Abelson
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

Review 10.  Mouse Anesthesia: The Art and Science.

Authors:  Kaela L Navarro; Monika Huss; Jennifer C Smith; Patrick Sharp; James O Marx; Cholawat Pacharinsak
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.